Work

Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.3010

Authors: John H. Sampson, Gordana Vlahovic, Solmaz Sahebjam, Antonio Marcilio Padula Omuro, Joachim M. Baehring, David A Hafler, Alfredo Daniel Voloschin, Prashni Paliwal, Joseph Grosso, Vlad Coric, Timothy F. Cloughesy, Michael Lim, David A. Reardon

Institutions: Duke Medical Center, Moffitt Cancer Center, Memorial Sloan Kettering Cancer Center, Yale University, Emory University, Bristol-Myers Squibb (United States), University of California, Los Angeles, Johns Hopkins Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2472428875

Cites:

Cited by: 70

Related to: 10